An adaptive approach to implementing bivariate group sequential clinical trial designs.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Sequential Analysis

Background:

• Clinical trials often require simultaneous monitoring of multiple patient responses (e.g., efficacy and safety).
• Existing group sequential test theories for bivariate responses assume known covariance and require pre-specification of the correlation (rho) between test statistics.
• Difficulty in accurately quantifying rho can compromise trial error rates and statistical power.

Purpose of the Study:

• To illustrate the impact of incorrect rho specification on type I error and power in sequential clinical trials.
• To propose and evaluate an adaptive method for calculating rho from accumulating trial data.
• To provide formulas for estimating correlation in bivariate response settings for sequential analysis.

Main Methods:

• Demonstration of the effects of misspecified rho on type I error and power using theoretical examples.
• Derivation of formulas for calculating correlation coefficients from observed data during a trial.
• Development and evaluation of an adaptive sequential testing approach utilizing calculated rho estimates.

Main Results:

• Inappropriate rho specification can significantly distort type I error rates and reduce statistical power.
• The proposed formulas enable the estimation of correlation from interim trial data.
• The adaptive method using calculated rho demonstrates a viable approach for robust sequential monitoring.

Conclusions:

• Accurate rho estimation is vital for maintaining the integrity of sequential clinical trial designs.
• The proposed adaptive method offers a practical solution to the challenge of rho specification.
• The derived formulas and adaptive approach are applicable to bivariate and multivariate sequential analyses.